335 related articles for article (PubMed ID: 34716856)
21. PAG1 directs SRC-family kinase intracellular localization to mediate receptor tyrosine kinase-induced differentiation.
Foltz L; Palacios-Moreno J; Mayfield M; Kinch S; Dillon J; Syrenne J; Levy T; Grimes M
Mol Biol Cell; 2020 Sep; 31(20):2269-2282. PubMed ID: 32726167
[TBL] [Abstract][Full Text] [Related]
22. Discoidin domain receptor tyrosine kinases: new players in cancer progression.
Valiathan RR; Marco M; Leitinger B; Kleer CG; Fridman R
Cancer Metastasis Rev; 2012 Jun; 31(1-2):295-321. PubMed ID: 22366781
[TBL] [Abstract][Full Text] [Related]
23. A systematic approach to therapeutic target selection in oesophago-gastric cancer.
Paterson AL; Shannon NB; Lao-Sirieix P; Ong CA; Peters CJ; O'Donovan M; Fitzgerald RC
Gut; 2013 Oct; 62(10):1415-24. PubMed ID: 22773546
[TBL] [Abstract][Full Text] [Related]
24. Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells.
Sattu K; Hochgräfe F; Wu J; Umapathy G; Schönherr C; Ruuth K; Chand D; Witek B; Fuchs J; Li PK; Hugosson F; Daly RJ; Palmer RH; Hallberg B
FEBS J; 2013 Nov; 280(21):5269-82. PubMed ID: 23889739
[TBL] [Abstract][Full Text] [Related]
25. Monitoring interactions between receptor tyrosine kinases and their downstream effector proteins in living cells using bioluminescence resonance energy transfer.
Tan PK; Wang J; Littler PL; Wong KK; Sweetnam TA; Keefe W; Nash NR; Reding EC; Piu F; Brann MR; Schiffer HH
Mol Pharmacol; 2007 Dec; 72(6):1440-6. PubMed ID: 17715395
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid induces functional c-Ret tyrosine kinase in human neuroblastoma.
Yamada S; Nomura T; Uebersax L; Matsumoto K; Fujita S; Miyake M; Miyake J
Neuroreport; 2007 Mar; 18(4):359-63. PubMed ID: 17435603
[TBL] [Abstract][Full Text] [Related]
27. Mutation-introduced dimerization of receptor tyrosine kinases: from protein structure aberrations to carcinogenesis.
Hu H; Liu Y; Jiang T
Tumour Biol; 2015 Mar; 36(3):1423-8. PubMed ID: 25750036
[TBL] [Abstract][Full Text] [Related]
28. All Good Things Must End: Termination of Receptor Tyrosine Kinase Signal.
Margiotta A
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198477
[TBL] [Abstract][Full Text] [Related]
29. Application of computational approaches to study signalling networks of nuclear and Tyrosine kinase receptors.
Choura M; Rebaï A
Biol Direct; 2010 Oct; 5():58. PubMed ID: 20937105
[TBL] [Abstract][Full Text] [Related]
30. Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines.
Miyake I; Hakomori Y; Shinohara A; Gamou T; Saito M; Iwamatsu A; Sakai R
Oncogene; 2002 Aug; 21(38):5823-34. PubMed ID: 12185581
[TBL] [Abstract][Full Text] [Related]
31. Pulling back the curtain: The hidden functions of receptor tyrosine kinases in development.
Clark JF; Soriano PM
Curr Top Dev Biol; 2022; 149():123-152. PubMed ID: 35606055
[TBL] [Abstract][Full Text] [Related]
32. TAM Receptor Tyrosine Kinases in Cancer Drug Resistance.
Vouri M; Hafizi S
Cancer Res; 2017 Jun; 77(11):2775-2778. PubMed ID: 28526769
[TBL] [Abstract][Full Text] [Related]
33. Receptor Tyrosine Kinases: Translocation Partners in Hematopoietic Disorders.
Nelson KN; Peiris MN; Meyer AN; Siari A; Donoghue DJ
Trends Mol Med; 2017 Jan; 23(1):59-79. PubMed ID: 27988109
[TBL] [Abstract][Full Text] [Related]
34. Proteome-Wide Detection and Annotation of Receptor Tyrosine Kinases (RTKs): RTK-PRED and the TyReK Database.
Filis G; Baltoumas FA; Spanogiannis G; Litou ZI; Iconomidou VA
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830638
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer.
Yeh CY; Shin SM; Yeh HH; Wu TJ; Shin JW; Chang TY; Raghavaraju G; Lee CT; Chiang JH; Tseng VS; Lee YC; Shen CH; Chow NH; Liu HS
BMC Cancer; 2011 Apr; 11():139. PubMed ID: 21496277
[TBL] [Abstract][Full Text] [Related]
36. Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.
Nair A; Chung HC; Sun T; Tyagi S; Dobrolecki LE; Dominguez-Vidana R; Kurley SJ; Orellana M; Renwick A; Henke DM; Katsonis P; Schmitt E; Chan DW; Li H; Mao S; Petrovic I; Creighton CJ; Gutierrez C; Dubrulle J; Stossi F; Tyner JW; Lichtarge O; Lin CY; Zhang B; Scott KL; Hilsenbeck SG; Sun J; Yu X; Osborne CK; Schiff R; Christensen JG; Shields DJ; Rimawi MF; Ellis MJ; Shaw CA; Lewis MT; Westbrook TF
Nat Med; 2018 May; 24(4):505-511. PubMed ID: 29578538
[TBL] [Abstract][Full Text] [Related]
37. Receptor tyrosine kinases and their activation in melanoma.
Easty DJ; Gray SG; O'Byrne KJ; O'Donnell D; Bennett DC
Pigment Cell Melanoma Res; 2011 Jun; 24(3):446-61. PubMed ID: 21320293
[TBL] [Abstract][Full Text] [Related]
38. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases.
Ostman A; Böhmer FD
Trends Cell Biol; 2001 Jun; 11(6):258-66. PubMed ID: 11356362
[TBL] [Abstract][Full Text] [Related]
39. Receptor tyrosine kinases: from biology to pathology.
Choura M; Rebaï A
J Recept Signal Transduct Res; 2011 Dec; 31(6):387-94. PubMed ID: 22040163
[TBL] [Abstract][Full Text] [Related]
40. Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation.
Jiao Y; Ou W; Meng F; Zhou H; Wang A
Mol Cancer; 2011 Sep; 10():125. PubMed ID: 21962244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
